Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Brainstorm Cell diskutieren

Brainstorm Cell

WKN: A12BXW / Symbol: BCLI / Name: Brainstorm Cell / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,44 €
19,62 %

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat

Einschätzung Buy
Rendite (%) -77,30 %
Kursziel 9,19
Veränderung
Endet am 31.03.24

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) had its price target raised by analysts at Maxim Group from $5.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for BCLI provided by MarketBeat